Affiliation:
1. Centre for Health Economics and Medicines Evaluation, Bangor University, Bangor LL57 2PZ, UK
2. Faculty of Nursing and Midwifery, Royal College of Surgeons in Ireland, D02 YN77 Dublin, Ireland
Abstract
In Wales, the prevalence of Type 2 Diabetes Mellitus (T2DM) has increased from 7.3% in 2016 to 8% in 2020, creating a major concern for the National Health Service (NHS). Social prescribing (SP) has been found to decrease T2DM prevalence and improve wellbeing. The MY LIFE programme, a scheme evaluated between June 2021 and February 2022 in the Conwy West Primary Care Cluster, aimed to prevent T2DM by referring prediabetic patients with a BMI of ≥30 to a diabetes technician (DT), who then signposted patients to community-based SP programmes, such as the National Exercise Referral Scheme (NERS), KindEating, and Slimming World. Although some patients engaged with SP, others chose to connect only with the DT. A Social Return on Investment (SROI) analysis was conducted to evaluate those patients who engaged with the DT plus SP, and those who connected solely with the DT. Relevant participant outcomes included ‘mental wellbeing’ and ‘good overall health’, which were measured at baseline (n = 54) and at the eight-week follow-up (n = 24). The estimated social value for every GBP 1 invested for participants who engaged with the ‘DT only’ ranged from GBP 4.67 to 4.70. The social value for participants who engaged with the ‘DT plus SP programme’ ranged from GBP 4.23 to 5.07. The results indicated that most of the social value generated was associated with connecting with the DT.
Funder
Bangor University and Conwy West Primary Care Cluster
Subject
Health, Toxicology and Mutagenesis,Public Health, Environmental and Occupational Health
Reference36 articles.
1. Therapeutic use of intermittent fasting for people with type 2 diabetes as an alternative to insulin;Furmli;Br. Med. J. Case Rep.,2018
2. Benefits of modest weight loss in improving cardiovascular risk factors in overweight and obese individuals with type 2 diabetes;Wing;Diabetes Care,2011
3. Prevalence and coprevalence of chronic comorbid conditions in patients with type 2 diabetes in Catalonia: A population-based cross-sectional study;Real;BMJ Open,2019
4. Kaur, G., Lakshmi PV, M., Rastogi, A., Bhansali, A., Jain, S., Teerawattananon, Y., and Prinja, S. (2020). Diagnostic accuracy of tests for type 2 diabetes and prediabetes: A systematic review and meta-analysis. PLoS ONE, 15.
5. NHS England (2022, April 22). NHS England Impact Analysis of Implementing NHS Diabetes Prevention Programme, 2016 to 2021. NHS England. Available online: https://www.england.nhs.uk/ltphimenu/diabetes-prevention/nhs-diabetes-prevention-programme-nhs-dpp/.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Social Prescribing in Wales;Social Prescribing Policy, Research and Practice;2024